To receive daily emails from Breaking Christian News to your inbox CLICK HERE


SHARE THIS ARTICLE Printer friendly version of this page

Drug Developed in Israel Saves 47 of 50 Severe Covid Patients in Trial

Abigail Klein Leichman : Nov 29, 2021  ISRAEL21c.org

Bonus BioGroup says its MesenCure experimental treatment resulted in 94% survival rate of trial subjects and cut hospitalization time in half.

[ISRAEL21c.org] Israel's Bonus BioGroup reports a survival rate of 94 percent (47 of 50) of the severe Covid-19 patients treated with its drug product MesenCure in a Phase II, multicenter clinical trial. (Image: Illustrative photo of Covid-19 patient at Kaplan Medical Center in Rehovot, one of three Israeli hospitals that participated in Phase II trials of MesenCure by Bonus BioGroup. /Credit: Yossi Aloni-Flash90 /via ISRAEL21c.org)

Study results, soon to be published, show MesenCure treatment reduced study participants' hospitalization period by about half compared to a control group. All these patients had life-threatening pneumonia and respiratory distress caused by Covid-19.

The data shows that MesenCure treatment reduced mortality by about 70% compared with the control group. Only two of the first 30 severe Covid-19 patients treated with MesenCure died due to Covid-19 or its complications, while 14 of 60 similar patients in the control group died.

MesenCure treatment shortened the hospitalization period of severe Covid-19 patients by eight days on average, a reduction of 45% relative to the control group.

The experimental group included women and men aged 41.4 to 77.4. About 77% of the severe Covid-19 patients treated in three hospitals with MesenCure had one or more risk factors for poor prognosis: hypertension, hyperlipidemia, obesity and Type 2 diabetes. Most were treated during the fourth Covid-19 wave in Israel, dominated by the Delta strain.

The control group received the current standard of care — anti-inflammatory drugs in combination with steroids. This regimen, according to Bonus BioGroup, reduces mortality in hospitalized Covid-19 patients only slightly, from 25.8% to 21.8%, indicating that MesenCure is four times more effective.

"We are proud of our success in leading the world to be a safer place by developing a medication for severe Covid-19 patients, thereby dramatically reducing the threat to their lives," said Dr. Shai Meretzki, CEO of Bonus BioGroup.

"In less than two years from the epidemic outbreak, we are the first in the world to report an effective and significant treatment for severely ill patients."

According to a statement from Bonus BioGroup, an independent expert committee confirmed the findings of the Phase II clinical trial of MesenCure and recommended continuing toward Phase III. Meretzki told the Jerusalem Post that the company will apply for emergency use approval from European and US regulatory agencies. Subscribe for free to Breaking Christian News here







SHARE THIS ARTICLE Printer friendly version of this page

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Other Recent Articles from Breaking Christian News

PRAY: Biden Administration Orders Embassy Workers Out of Ukraine, Warns US Citizens

Florida Legislature Advances 15-Week Abortion Ban Supported by Gov. DeSantis

Gov DeSantis SLAMS Biden's FDA for Abruptly Closing Florida's 'Lifesaving' Treatment Sites

'We Don't Want the School District to Be the Parent': Florida Bill Limits Lessons on Sexual Orientation, Gender

Commentary: Democrats Rushed to 'Reimagine' Policing in Washington State. Now It's Unsafe

Biden Fails 'Big Mac Test'; Inflation Hits 40 Year High, As He Curses Out Reporter at White House Meeting

Surprise: Biden's DOJ Defending Major Trump Immigration Policies

God Is at Work! Here Are Some Highlights from Recent Headline Prayer to Encourage You

Pro Life Victory!: Planned Parenthood Abandons Legal Challenge to Lubbock's Abortion Ban at the US 5th Circuit Court of Appeals

Grassroots Efforts Halt Planned Parenthood Abortion Facility Construction in Upstate New York

'Every Child Matters': Popular Priest Fr. Mike Schmitz Gave Epic Keynote Speech at 2022 March For Life

Federal Court Blocks Biden's Federal Employee Vaccine Mandate: 'A Bridge too Far'

Between 30,000 - 35,000 Attend 'Defeat the Mandates' March in DC Calling for End to 'Draconian' COVID-19 Vax Requirements

In a Surprise Move, Ireland's Prime Minister Announces Most COVID Restrictions Will Be Lifted

Imminent Invasion? US Boosts NATO, Pulls Embassy Families from Ukraine as Russia's Aggression Spark Fears of War

'Please, Please!': Intense Bodycam Footage Shows Fearless Texas Officer Save Unconscious Woman Trapped in Blazing Car [Watch]

'I Made My Faith Public': Celebs React as Country Singer and Actress Jana Kramer Gets Baptized, Praises God

Thousands Flood to Washington, DC to 'Banner Year' March For Life

Tens of Thousands 'Shut Down' DC in March For Life 2022; the 'Biggest Event in Washington You Won't Hear About in Mainstream Media'

Supreme Court Denies Abortionists' Bid to Have Liberal District Judge Rule on the Texas Heartbeat Act



Search the Articles Archives

Keyword:  
Author:  
Words Posted On:  
Day Month Year



BCN Plus

An BCN Paid Advertisement
An BCN Paid Advertisement
Follow BCN on Twitter
Are You Praying for Our Government Leaders?
BCN Staff

Steve Shultz
Steve Shultz, Managing Editor
Founder and Owner


Aimee Herd
Aimee Herd, Editor


BCN Plus
Are You Praying for President Trump?
 
 

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.


Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved


Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.

editor@breakingchristiannews.com